إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - brimonidine tartrate 0.15 %w/v - ophthalmic solution - brimonidine - for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - dorzolamide as hydrochloride 2 % - ophthalmic solution - dorzolamide - for the treatment of elevated intracular pressure (iop) in patients with ocular hypertension, open-angle glaucoma and in some patients with secondary glaucoma.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - dexamethasone as sodium phosphate 1 mg/ml; neomycin as sulfate 5 mg/ml - ophthalmic solution - neomycin - steroid-responsive allergic and inflammatory disorders of the anterior segments of the eye (conjunctival, corneal, or uveal tract inflammation) or mechanical, chemical or thermal trauma where bacterial infection or a risk of bacterial ocular infection exists.

إسرائيل - العربية - Ministry of Health

salomon,levin & elstein ltd - loteprednol etabonate 5 mg / 1 ml - ophthalmic suspension - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po

إسرائيل - العربية - Ministry of Health

pfizer pharmaceuticals israel ltd - latanoprost 50 mcg/ml - eye drops - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.

إسرائيل - العربية - Ministry of Health

pfizer pharmaceuticals israel ltd - latanoprost 50 mcg/ml; timolol as maleate 5 mg/ml - eye drops - other antiglaucoma preparations - reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers.

إسرائيل - العربية - Ministry of Health

abic marketing ltd - dorzolamide as hydrochloride 2 %; timolol as maleate 0.5 % - ophthalmic solution - timolol - for the treatment of elevated intracular pressure (iop) in patients with ocular hypertension, open-angle glaucoma, or other secondary open-angle glaucoma, when concomitant therapy is appropriate.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - alfacalcidol 0.25 mcg - capsules soft gelatin - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - alfacalcidol 1 mcg - capsules soft gelatin - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - mirtazapine 30 mg - tablets - mirtazapine - episode of major depression.